Boryung Pharmaceutical
Boryung Pharmaceutical Co., Ltd. is a South Korean company engaged in the research, development, production, and sale of a wide range of pharmaceutical products. Founded in 1963 and originally involved in wholesale, Boryung transitioned into manufacturing and focuses on developing essential medicines. Its product portfolio includes cardiovascular treatments, antibiotics, anticancer medications, amino acids, cosmetics, gastrointestinal products, and active pharmaceutical ingredients (APIs). Boryung exports its products to approximately 50 countries across six continents, including regions such as Japan, China, Southeast Asia, the Middle East, Europe, South America, and Africa. A notable achievement for the company was the introduction of "Kanarb," the first Angiotensin II Receptor Blocker antihypertensive medication in South Korea in 2011. Boryung is also committed to innovation and exploration in health, as demonstrated by its plans to host the inaugural Care in Space Challenge in 2022, reflecting its ambition to contribute to human health in an evolving technological landscape.
5 past transactions
Exobiosphere
Seed Round in 2025
Exobiosphere is a pioneering company that specializes in space-based biotechnology. It develops a unique research platform designed to accelerate preclinical testing in microgravity conditions. This platform automates the creation of disease models in space, enabling pharmaceutical companies to expedite drug development, identify novel targets, and enhance treatment efficacy across various therapeutic areas.
LambdaVision
Venture Round in 2024
LambdaVision, Incorporated is focused on developing a protein-based artificial retina aimed at restoring vision for individuals affected by advanced retinal degenerative diseases, such as retinitis pigmentosa and age-related macular degeneration. Founded in 2009 and based in Farmington, Connecticut, the company is commercializing a retinal implant that leverages light-activated proteins, specifically bacteriorhodopsin, to stimulate the retinas of patients with significant vision impairment. By providing innovative solutions for those suffering from these debilitating conditions, LambdaVision seeks to enhance the quality of life for millions of patients facing vision loss.
Axiom Space
Series C in 2023
Axiom Space, Inc. is a Houston, Texas-based company founded in 2016 that focuses on developing and operating commercial space station modules connected to the International Space Station (ISS). The company offers human spaceflight services to government astronauts, tourists, and private enterprises, facilitating research, manufacturing, and testing of space exploration technologies. Axiom Space aims to provide universal access to the ISS, conducting missions for both national and private astronauts, and enabling clients from various sectors to engage in space initiatives. The company leverages its platform in Low Earth Orbit and extensive experience in human spaceflight management to create new opportunities for advanced industries and future space exploration endeavors.
Myelin-H
Pre Seed Round in 2023
Myelin-H is a digital healthcare company focused on revolutionizing brain health monitoring for individuals affected by neurological disorders, including multiple sclerosis and other brain conditions. The company aims to empower over a billion people by providing a non-invasive, closed-loop brain-machine interface designed for remote monitoring and neurorehabilitation. Utilizing advanced neuromorphic software technology, Myelin-H’s platform can interpret multiple biosignals in real time, allowing for effective monitoring of conditions such as Parkinson's disease, particularly in elderly patients. Additionally, the company’s neurotechnology supports deep space missions by monitoring, training, and rehabilitating astronauts throughout their journeys.
CloudHospital
Seed Round in 2020
CloudHospital, founded in Seoul, South Korea, is an online platform designed to assist patients in locating the best medical providers globally, regardless of their location. The platform simplifies the process of finding and comparing healthcare services, enabling patients to access a wide range of options, from complex surgeries to advanced cosmetic procedures and routine health checkups. By leveraging technology, CloudHospital facilitates seamless connections between millions of patients and reputable hospitals and clinics worldwide. The service is available in multiple languages, including English, Chinese, and Russian, ensuring accessibility for a diverse clientele. With a commitment to providing quality healthcare solutions, CloudHospital also offers 24/7 customer support to assist users in navigating their medical care needs effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.